메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background and Objectives:Galectin-3 is a beta-galactoside binding protein, of which the major function is not fully elucidatedin malignant tumor. However, galectin-3 is expressed in epithelial cells and contributes to the progression of cancer. Althoughgalectin-3 is expressed in a variety of tissues and plays important roles in malignant transformation or tumor progression,the study on its expression related to clinicopathological parameters in thyroid tumor is rare. So, the present study aims to findout the clinical significance of galectin-3 in thyroid tumor. Subjects and Method:We assessed mRNA and protein expressionsof the galectin-3 gene by means of the RT-PCR method and immunohistochemical staining in 100 cases of thyroid tumors (50papillary carcinomas, 10 follicular carcinomas, 20 follicular adenomas, 20 nodular hyperplasia). The expression of galectin-3 iscompared with the clinical prognostic factors of thyroid papillary cancer. Results:Using RT-PCR, galectin-3 mRNA was detectedin 41 (82%) in papillary carcinoma, 6 (60%) in follicular carcinoma, 8 (40%) in follicular adenoma and 9 (45%) in nodularhyperplasia cases. Using immunohistochemical staining, galectin-3 protein expressions were detected in 46 (92%), 7(70%), 3 (15%) and 1 (5%). The expressions of the galectin-3 mRNA and protein were significantly recognized in thyroid papillarycarcinoma. However, the galectin-3 mRNA and protein over-expression is not significantly correlated with the clinicalprognostic factors of thyroid papillary carcinoma. Conclusion:These results suggest that galectin-3 expression may be associatedwith thyroid papillary carcinoma development. (Korean J Otolaryngol 2006;49:812-6)

목차

등록된 정보가 없습니다.

참고문헌 (11)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0